General Information of the Compound
Compound ID
CP0562602
Compound Name
4-(3-bromopyridin-2-yl)-N-(1H-indazol-5-yl)piperazine-1-carboxamide
    Show/Hide
Structure
Formula
C17H17BrN6O
Molecular Weight
401.268
Canonical SMILES
Brc1cccnc1N1CCN(CC1)C(=O)Nc1ccc2[nH]ncc2c1
    Show/Hide
InChI
InChI=1S/C17H17BrN6O/c18-14-2-1-5-19-16(14)23-6-8-24(9-7-23)17(25)21-13-3-4-15-12(10-13)11-20-22-15/h1-5,10-11H,6-9H2,(H,20,22)(H,21,25)
    Show/Hide
InChIKey
JOHWDOYBTQYCSO-UHFFFAOYSA-N
Physicochemical Property
logP
3.0745
Rotatable Bonds
2
Heavy Atom Count
25
Polar Areas
77.15
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168280116
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS